Back to search

Article

Post-irradiation Breast Angiosarcoma: All the Possible Treatments and Electrochemotherapy. Case Report and Literature Review.

2023-12-13

Abstract excerpt

Breast Angiosarcoma is a rare malignancy, accounting less than 1% of all soft tissue. It comprises primitive and secondary subtypes, such as radiogenic breast angiosarcoma (RAS). Despite the multimodal treatment, angiosarcomas represent an incurable disease for many patients and represent a cause of substantial deterioration of their quality of life. Surgery represents the cornerstone in the management, but high r...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
90a8367b-26c9-5552-856b-c42760c1001e
DOI
10.20944/preprints202312.0945.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Post-irradiation Breast Angiosarcoma: All the Possible Treatments and Electrochemotherapy. Case Report and Literature Review.DOI 10.20944/preprints202312.0945.v1
Breast Angiosarcoma: a SEER Population- Based StudySemantic proximity
Clinicopathological features, treatment outcomes, and prognostic factors of angiosarcoma: a 21-year experience at one centerSemantic proximity
Post-radiotherapy vascular lesions of the breast: immunohistochemical and molecular features of 74 cases with long-term follow-up and literature review.Semantic proximity
Mutational landscape of primary breast angiosarcoma with repeated resection and recurrence over a 15-year period: A case report.Semantic proximity
Clinicopathologic and molecular correlates to neoadjuvant chemotherapy-induced pathologic response in breast angiosarcoma.Semantic proximity
Cutaneous angiosarcoma: a current update.Semantic proximity
The impact of MYC gene amplification on the clinicopathological features and prognosis of radiation‐associated angiosarcomas of the breastSemantic proximity
Clinicopathologic and Molecular Analysis of Primary Angiosarcoma of Bone-A Single Institution Experience.Semantic proximity
Demographics, Prognostic Factors and Survival Outcomes in Hepatic Angiosarcoma: A Retrospective AnalysisSemantic proximity
New molecular targets in canine hemangiosarcoma-Comparative review and future of the precision medicine.Semantic proximity
Angiosarcoma heterogeneity and potential therapeutic vulnerability to immune checkpoint blockade: insights from genomic sequencing.Semantic proximity
Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single centerSemantic proximity
Select a neighboring publication to make it the new centre.